07 December 2016
Last week we hosted a Genesis fringe event to discuss the highly topical issue of anti-microbial resistance.
The meeting was held as part of a series of satellite seminars hosted in London on the day prior to the Genesis conference. The debate considered radically changing the treatment of anti-microbial resistant infections, and whether there is a business case, and was led by Martin MacLean alongside speakers from Public Health England, AMR Centre, Instinctif Partners, New Wave Ventures and Cantor Fitzgerald.
Sign up to our mailing list to receive Mathys Matters, our monthly newsletter covering the latest IP news, industry insights, events and case law.
If you are interested in receiving quarterly newsletters relevant to our core sector groups - IT & engineering ('Inside Wires') and life sciences & chemistry ('Under the Microscope') - please select your preference(s) below:
Please select your practice area(s) of interest: